- Home
- BIOX vs HRTX Comparison
BIOX vs HRTX Comparison
Compare BIOX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- HRTX
- Stock Information
- Founded
- BIOX 2001
- HRTX 1983
- Country
- BIOX Argentina
- HRTX United States
- Employees
- BIOX N/A
- HRTX N/A
- Industry
- BIOX Agricultural Chemicals
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- BIOX Industrials
- HRTX Health Care
- Exchange
- BIOX Nasdaq
- HRTX Nasdaq
- Market Cap
- BIOX 302.3M
- HRTX 325.0M
- IPO Year
- BIOX N/A
- HRTX 1987
- Fundamental
- Price
- BIOX $4.23
- HRTX $2.18
- Analyst Decision
- BIOX Strong Buy
- HRTX Strong Buy
- Analyst Count
- BIOX 4
- HRTX 2
- Target Price
- BIOX $8.63
- HRTX $5.00
- AVG Volume (30 Days)
- BIOX 138.4K
- HRTX 1.5M
- Earning Date
- BIOX 09-08-2025
- HRTX 08-05-2025
- Dividend Yield
- BIOX N/A
- HRTX N/A
- EPS Growth
- BIOX N/A
- HRTX N/A
- EPS
- BIOX N/A
- HRTX N/A
- Revenue
- BIOX $383,289,394.00
- HRTX $148,518,000.00
- Revenue This Year
- BIOX N/A
- HRTX $12.08
- Revenue Next Year
- BIOX $7.30
- HRTX $12.57
- P/E Ratio
- BIOX N/A
- HRTX N/A
- Revenue Growth
- BIOX N/A
- HRTX 12.43
- 52 Week Low
- BIOX $3.51
- HRTX $1.04
- 52 Week High
- BIOX $11.78
- HRTX $3.73
- Technical
- Relative Strength Index (RSI)
- BIOX 40.80
- HRTX 55.42
- Support Level
- BIOX $4.25
- HRTX $2.04
- Resistance Level
- BIOX $4.80
- HRTX $2.28
- Average True Range (ATR)
- BIOX 0.28
- HRTX 0.12
- MACD
- BIOX -0.04
- HRTX 0.01
- Stochastic Oscillator
- BIOX 10.47
- HRTX 63.64
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.